These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10739762)

  • 1. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen.
    Nuytinck L; Freund M; Lagae L; Pierard GE; Hermanns-Le T; De Paepe A
    Am J Hum Genet; 2000 Apr; 66(4):1398-402. PubMed ID: 10739762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
    Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
    Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
    Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
    Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.
    De Paepe A; Nuytinck L; Hausser I; Anton-Lamprecht I; Naeyaert JM
    Am J Hum Genet; 1997 Mar; 60(3):547-54. PubMed ID: 9042913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.
    Nicholls AC; Oliver JE; McCarron S; Harrison JB; Greenspan DS; Pope FM
    J Med Genet; 1996 Nov; 33(11):940-6. PubMed ID: 8950675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I.
    Michalickova K; Susic M; Willing MC; Wenstrup RJ; Cole WG
    Hum Mol Genet; 1998 Feb; 7(2):249-55. PubMed ID: 9425231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen.
    Narcisi P; Richards AJ; Ferguson SD; Pope FM
    Hum Mol Genet; 1994 Sep; 3(9):1617-20. PubMed ID: 7833919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
    Giunta C; Steinmann B
    Am J Med Genet; 2000 Jan; 90(1):72-9. PubMed ID: 10602121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
    Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
    Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.
    Cabral WA; Makareeva E; Colige A; Letocha AD; Ty JM; Yeowell HN; Pals G; Leikin S; Marini JC
    J Biol Chem; 2005 May; 280(19):19259-69. PubMed ID: 15728585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The substitution of glycine 661 by arginine in type III collagen produces mutant molecules with different thermal stabilities and causes Ehlers-Danlos syndrome type IV.
    Richards A; Narcisi P; Lloyd J; Ferguson C; Pope FM
    J Med Genet; 1993 Aug; 30(8):690-3. PubMed ID: 8411057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
    Chiodo AA; Sillence DO; Cole WG; Bateman JF
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.
    Burrows NP; Nicholls AC; Richards AJ; Luccarini C; Harrison JB; Yates JR; Pope FM
    Am J Hum Genet; 1998 Aug; 63(2):390-8. PubMed ID: 9683580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).
    Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M
    J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.
    Takahara K; Schwarze U; Imamura Y; Hoffman GG; Toriello H; Smith LT; Byers PH; Greenspan DS
    Am J Hum Genet; 2002 Sep; 71(3):451-65. PubMed ID: 12145749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehlers-Danlos syndrome type IV caused by Gly400Glu, Gly595Cys and Gly1003Asp substitutions in collagen III: clinical features, biochemical screening, and molecular confirmation.
    Mackay K; Raghunath M; Superti-Furga A; Steinmann B; Dalgleish R
    Clin Genet; 1996 Jun; 49(6):286-95. PubMed ID: 8884076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ehlers-Danlos syndrome and type III collagen abnormalities: a variable clinical spectrum.
    Hamel BC; Pals G; Engels CH; van den Akker E; Boers GH; van Dongen PW; Steijlen PM
    Clin Genet; 1998 Jun; 53(6):440-6. PubMed ID: 9712532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.